P&G Guides FY Adjusted EPS to $6.89-$7.11
PG sits 15% above its 52-week low of $137.62.
Summary
P&G issued fiscal-year adjusted EPS guidance of $6.89 to $7.11 and now expects fiscal 2027 all-in sales growth of 2% to 4%. That follows a fiscal 2026 where core EPS grew only 1% and Q4 diluted EPS fell 15%, and it comes after management flagged a $1 billion after-tax cost headwind for fiscal 2027 from raw materials, energy and transportation. The range implies modest growth off that depressed base rather than a recovery in margins. In the fiscal first quarter, EPS was $1.97 and adjusted EPS was $2.00 on sales of $23.3 billion and net income of $4.73 billion, with operating cash flow of $5.77 billion and adjusted free cash flow productivity of 93%. The Thorne acquisition adds a premium wellness brand but is small relative to a company of this size. Watch the fiscal Q1 report for whether the cost headwind is tracking at, above, or below the $1 billion estimate.
At the time of this announcement, PG was trading at $158.50 on NYSE in the Manufacturing sector, with a market capitalization of approximately $364.3B. The 52-week trading range was $137.62 to $167.25. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.